# Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation

> **NCT02247128** · PHASE4 · COMPLETED · sponsor: **St. Antonius Hospital** · enrollment: 1016 (actual)

## Conditions studied

- Aortic Valve Disease
- Myocardial Infarction
- Stroke
- Bleeding

## Interventions

- **DRUG:** Aspirin + clopidogrel
- **DRUG:** Aspirin monotherapy
- **DRUG:** OAC + clopicogrel
- **DRUG:** OAC monotherapy

## Key facts

- **NCT ID:** NCT02247128
- **Lead sponsor:** St. Antonius Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2020-03
- **Final completion:** 2020-04
- **Target enrollment:** 1016 (ACTUAL)
- **Last updated:** 2020-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02247128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02247128, "Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02247128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*